Selected research
Industry Research
Brain Health Products Industry Research Report 2026
Market perspective
The global Brain Health Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Brain Health Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Brain Health Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Brain Health Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Brain Health Products include Yuwangpharma, Velnex Medicare, Unilever Global, Synergy CHC, Reckitt Benckiser Group plc., Quincy Bioscience, Ocean Health Pte Ltd., Neuriva and Natural Factors, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Brain Health Products market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Brain Health Products.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Brain Health Products Market by Company
Yuwangpharma
Velnex Medicare
Unilever Global
Synergy CHC
Reckitt Benckiser Group plc.
Quincy Bioscience
Ocean Health Pte Ltd.
Neuriva
Natural Factors
Natrol, LLC.
Lifelab Manufacturing
GNC Holdings, LLC
DSM-Firmenich
BL Bio Lab
AdvaCare Pharma
Brain Health Products Segment by Type
Plant Extracts
Fatty Acids
Vitamins
Others
Brain Health Products Segment by Application
Online Sales
Offline Sales
Brain Health Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brain Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Brain Health Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plant Extracts
- Fatty Acids
- Vitamins
- Others
Applications
- Online Sales
- Offline Sales
Companies covered
- Yuwangpharma
- Velnex Medicare
- Unilever Global
- Synergy CHC
- Reckitt Benckiser Group plc.
- Quincy Bioscience
- Ocean Health Pte Ltd.
- Neuriva
- Natural Factors
- Natrol, LLC.
- Lifelab Manufacturing
- GNC Holdings, LLC
- DSM-Firmenich
- BL Bio Lab
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Brain Health Products by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Plant Extracts
- 2.2.3 Fatty Acids
- 2.2.4 Vitamins
- 2.2.5 Others
- 2.3 Brain Health Products by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Online Sales
- 2.3.3 Offline Sales
- 2.4 Assumptions and Limitations
3 Brain Health Products Breakdown Data by Type
- 3.1 Global Brain Health Products Historic Market Size by Type (2021-2026)
- 3.2 Global Brain Health Products Forecasted Market Size by Type (2027-2032)
4 Brain Health Products Breakdown Data by Application
- 4.1 Global Brain Health Products Historic Market Size by Application (2021-2026)
- 4.2 Global Brain Health Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Brain Health Products Market Perspective (2021-2032)
- 5.2 Global Brain Health Products Growth Trends by Region
- 5.2.1 Global Brain Health Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Brain Health Products Historic Market Size by Region (2021-2026)
- 5.2.3 Brain Health Products Forecasted Market Size by Region (2027-2032)
- 5.3 Brain Health Products Market Dynamics
- 5.3.1 Brain Health Products Industry Trends
- 5.3.2 Brain Health Products Market Drivers
- 5.3.3 Brain Health Products Market Challenges
- 5.3.4 Brain Health Products Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Brain Health Products Players by Revenue
- 6.1.1 Global Top Brain Health Products Players by Revenue (2021-2026)
- 6.1.2 Global Brain Health Products Revenue Market Share by Players (2021-2026)
- 6.2 Global Brain Health Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Brain Health Products Head Office and Area Served
- 6.4 Global Brain Health Products Players, Product Type & Application
- 6.5 Global Brain Health Products Manufacturers Established Date
- 6.6 Global Brain Health Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Brain Health Products Market Size (2021-2032)
- 7.2 North America Brain Health Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Brain Health Products Market Size by Country (2021-2026)
- 7.4 North America Brain Health Products Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Brain Health Products Market Size (2021-2032)
- 8.2 Europe Brain Health Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Brain Health Products Market Size by Country (2021-2026)
- 8.4 Europe Brain Health Products Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Brain Health Products Market Size (2021-2032)
- 9.2 Asia-Pacific Brain Health Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Brain Health Products Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Brain Health Products Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Brain Health Products Market Size (2021-2032)
- 10.2 South America Brain Health Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Brain Health Products Market Size by Country (2021-2026)
- 10.4 South America Brain Health Products Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Brain Health Products Market Size (2021-2032)
- 11.2 Middle East & Africa Brain Health Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Brain Health Products Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Brain Health Products Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Yuwangpharma
- 12.1.1 Yuwangpharma Company Information
- 12.1.2 Yuwangpharma Business Overview
- 12.1.3 Yuwangpharma Revenue in Brain Health Products Business (2021-2026)
- 12.1.4 Yuwangpharma Brain Health Products Product Portfolio
- 12.1.5 Yuwangpharma Recent Developments
- 12.2 Velnex Medicare
- 12.2.1 Velnex Medicare Company Information
- 12.2.2 Velnex Medicare Business Overview
- 12.2.3 Velnex Medicare Revenue in Brain Health Products Business (2021-2026)
- 12.2.4 Velnex Medicare Brain Health Products Product Portfolio
- 12.2.5 Velnex Medicare Recent Developments
- 12.3 Unilever Global
- 12.3.1 Unilever Global Company Information
- 12.3.2 Unilever Global Business Overview
- 12.3.3 Unilever Global Revenue in Brain Health Products Business (2021-2026)
- 12.3.4 Unilever Global Brain Health Products Product Portfolio
- 12.3.5 Unilever Global Recent Developments
- 12.4 Synergy CHC
- 12.4.1 Synergy CHC Company Information
- 12.4.2 Synergy CHC Business Overview
- 12.4.3 Synergy CHC Revenue in Brain Health Products Business (2021-2026)
- 12.4.4 Synergy CHC Brain Health Products Product Portfolio
- 12.4.5 Synergy CHC Recent Developments
- 12.5 Reckitt Benckiser Group plc.
- 12.5.1 Reckitt Benckiser Group plc. Company Information
- 12.5.2 Reckitt Benckiser Group plc. Business Overview
- 12.5.3 Reckitt Benckiser Group plc. Revenue in Brain Health Products Business (2021-2026)
- 12.5.4 Reckitt Benckiser Group plc. Brain Health Products Product Portfolio
- 12.5.5 Reckitt Benckiser Group plc. Recent Developments
- 12.6 Quincy Bioscience
- 12.6.1 Quincy Bioscience Company Information
- 12.6.2 Quincy Bioscience Business Overview
- 12.6.3 Quincy Bioscience Revenue in Brain Health Products Business (2021-2026)
- 12.6.4 Quincy Bioscience Brain Health Products Product Portfolio
- 12.6.5 Quincy Bioscience Recent Developments
- 12.7 Ocean Health Pte Ltd.
- 12.7.1 Ocean Health Pte Ltd. Company Information
- 12.7.2 Ocean Health Pte Ltd. Business Overview
- 12.7.3 Ocean Health Pte Ltd. Revenue in Brain Health Products Business (2021-2026)
- 12.7.4 Ocean Health Pte Ltd. Brain Health Products Product Portfolio
- 12.7.5 Ocean Health Pte Ltd. Recent Developments
- 12.8 Neuriva
- 12.8.1 Neuriva Company Information
- 12.8.2 Neuriva Business Overview
- 12.8.3 Neuriva Revenue in Brain Health Products Business (2021-2026)
- 12.8.4 Neuriva Brain Health Products Product Portfolio
- 12.8.5 Neuriva Recent Developments
- 12.9 Natural Factors
- 12.9.1 Natural Factors Company Information
- 12.9.2 Natural Factors Business Overview
- 12.9.3 Natural Factors Revenue in Brain Health Products Business (2021-2026)
- 12.9.4 Natural Factors Brain Health Products Product Portfolio
- 12.9.5 Natural Factors Recent Developments
- 12.10 Natrol, LLC.
- 12.10.1 Natrol, LLC. Company Information
- 12.10.2 Natrol, LLC. Business Overview
- 12.10.3 Natrol, LLC. Revenue in Brain Health Products Business (2021-2026)
- 12.10.4 Natrol, LLC. Brain Health Products Product Portfolio
- 12.10.5 Natrol, LLC. Recent Developments
- 12.11 Lifelab Manufacturing
- 12.11.1 Lifelab Manufacturing Company Information
- 12.11.2 Lifelab Manufacturing Business Overview
- 12.11.3 Lifelab Manufacturing Revenue in Brain Health Products Business (2021-2026)
- 12.11.4 Lifelab Manufacturing Brain Health Products Product Portfolio
- 12.11.5 Lifelab Manufacturing Recent Developments
- 12.12 GNC Holdings, LLC
- 12.12.1 GNC Holdings, LLC Company Information
- 12.12.2 GNC Holdings, LLC Business Overview
- 12.12.3 GNC Holdings, LLC Revenue in Brain Health Products Business (2021-2026)
- 12.12.4 GNC Holdings, LLC Brain Health Products Product Portfolio
- 12.12.5 GNC Holdings, LLC Recent Developments
- 12.13 DSM-Firmenich
- 12.13.1 DSM-Firmenich Company Information
- 12.13.2 DSM-Firmenich Business Overview
- 12.13.3 DSM-Firmenich Revenue in Brain Health Products Business (2021-2026)
- 12.13.4 DSM-Firmenich Brain Health Products Product Portfolio
- 12.13.5 DSM-Firmenich Recent Developments
- 12.14 BL Bio Lab
- 12.14.1 BL Bio Lab Company Information
- 12.14.2 BL Bio Lab Business Overview
- 12.14.3 BL Bio Lab Revenue in Brain Health Products Business (2021-2026)
- 12.14.4 BL Bio Lab Brain Health Products Product Portfolio
- 12.14.5 BL Bio Lab Recent Developments
- 12.15 AdvaCare Pharma
- 12.15.1 AdvaCare Pharma Company Information
- 12.15.2 AdvaCare Pharma Business Overview
- 12.15.3 AdvaCare Pharma Revenue in Brain Health Products Business (2021-2026)
- 12.15.4 AdvaCare Pharma Brain Health Products Product Portfolio
- 12.15.5 AdvaCare Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst